Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nexoptic Technology Corp V.NXO

Alternate Symbol(s):  NXOPF

NexOptic Technology Corp. is a Canada-based technology company. The Company is engaged in developing artificial intelligence (AI) and imaging products, which enhance how images are either captured, processed, experienced, transferred and/or stored. It is developing technologies relating to imagery and light concentration for lens and image capture systems. The Company's primary focus is its patented and patent pending AI for imaging called All Light Intelligent Imaging Solutions (Aliis). Aliis can reduce storage and streaming requirements needed for videos and images while also improving image quality in all types of environmental conditions. Aliis delivers by learning a camera profile and optimally enhancing, pixel by pixel, its quality and its resolution in a fraction of a second, using edge processing. Its NexCompress, a video compression enhancement solution, offers bandwidth and storage savings for video storage and streaming applications.


TSXV:NXO - Post by User

Comment by InvestAIon Jun 13, 2022 2:54pm
104 Views
Post# 34752877

RE:RE:RE:RE:RE:RE:Short reply ...

RE:RE:RE:RE:RE:RE:Short reply ...

stockmonster6 :   Thanks for your feedback.

- On April 7, 2021 NXO announced a partnership with Prestine Surgical.

- On March 17, 2020 Prestine Surgical completed a capital raise of $18 million.

- On March 2, 2022 Prestine Surgical had a financing (for commercialization) of $15 million.

- FDA cleared (510k) according to a Video dated March 3, 2022.

Bryan Lord, CEO of Pristine Surgical || LSI 2021 Emerging Medtech Summit

https://youtu.be/3QkWhCRwGOM

They wanted to be ready by end of 2021 something like that, but sometimes certain steps need more time. I can only guess now, possibly in 2022. Would be great.

 

Regards,

InvestAI

 

 

 


<< Previous
Bullboard Posts
Next >>